医用大麻及其在治疗骨关节炎疼痛和功能方面的疗效
Cerina Dubois1,2, Elizabeth C Danielson1, Molly Beestrum1
1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Current medical research and opinion
|June 4, 2024
概括
医用大麻可能为一些骨关节炎患者提供疼痛缓解,可能减少阿片类药物的使用. 然而,证据质量较低,表明它不是主要治疗的替代品.
科学领域:
- 类风湿病学 类风湿病学
- 疼痛管理 疼痛管理
- 大麻素药物医学 大麻素医药
背景情况:
- 骨关节炎 (OA) 的管理通常涉及药物治疗.
- 增加患者对医用大麻的兴趣,以缓解OA症状并减少阿片类药物依赖.
- 需要评估关于医用大麻治疗OA疼痛和功能功效的全球证据.
研究的目的:
- 系统地审查全球关于使用医用大麻治疗骨关节炎 (OA) 疼痛和功能的证据.
- 评估医用大麻对OA症状管理和阿片类药物处方减少的影响.
主要方法:
- 在2012-2022年期间发表在MEDLINE,Embase和CINAHL的研究的系统综述.
- 包括使用医用大麻的成年OA患者;不包括灰色文献和案例研究.
- 使用GRADE和ROBINS-I评估研究质量和偏差风险;使用叙事合成.
主要成果:
- 包括7项研究 (2项RCT,5项观察性) 在内.
- 一个RCT报告疼痛改善;所有观察性研究显示疼痛改善,减少阿片类药物使用或更好的功能.
- 尽管研究的局限性,共识表明医用大麻对一小部分OA患者的有效性,尽管研究的局限性.
结论:
- 低质量的证据支持OA的医用大麻,但它不能替代初级药理治疗.
- 医用大麻可能为患有骨关节炎的特定个体提供治疗益处.
相关概念视频
Analgesia and Pain Management
579
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
579
Opioid Analgesics: Synthetic and Semisynthetic Opioids
276
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
276
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
224
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
224


